Your basket is currently empty!
Kidney Cancer UK represents patients at NICE nivo+ipi appraisal
On 3rd February 2022, NICE approve the use of nivolumab with ipilimumab as a first line treatment for kidney ...
News Archive
NICE
Our work depends on donations from generous people so that we can support those affected by kidney cancer.
Would you like to support our work through a donation?
